National Institute of Allergy and Infectious Diseases

RFA-AI-22-012: 2022 Immune Drivers of Autoimmune Disease (IDAD) (U01 Clinical Trial Not Allowed)

No applicants // Limit: 1 // Tickets Available: 1 

 

This FOA invites applications to participate in the Immune Drivers of Autoimmune Disease (IDAD) cooperative research program, which will focus on defining the immunologic states and dynamics that drive autoimmune disease. The main objective of this program is to enhance our understanding of the immunologic processes, events, and changes that underlie the clinical manifestations of autoimmune diseases, including disease flare, remission, and progression of established disease, as well as the progression from a state of elevated risk to clinical diagnosis of autoimmune disease.

Internal Deadline
External Deadline
07/01/2022

RFA-AI-22-019: 2022 Emergency Awards: Biocontainment Facility Improvements and Building System Upgrades to Support Pandemic Preparedness (G20 Clinical Trial Not Allowed)

No applicants // Limit: 1 // Tickets Available: 1 

 

The purpose of this Funding Opportunity Announcement (FOA) is to support pandemic preparedness by providing an opportunity for facility improvements and building systems upgrades at existing BSL3 and BSL4 biocontainment laboratories engaged in research on RNA viruses of pandemic potential to facilitate the conduct of biomedical research on vaccines and therapeutics. NIAID is issuing this FOA in response to the declared public health emergency issued by the Secretary, HHS, for the 2019 Novel Coronavirus (COVID-19), and within the provisions described in the "American Rescue Plan Act of 2021

Limited Submission language from the solicitation:

Only one application per institution is allowed, as defined in Section III. 3. Additional Information on Eligibility.

Internal Deadline
External Deadline
04/19/2022

Centers for HIV Structural Biology (U54 Clinical Trial Not Allowed)

No applicants // Limit: 1 // Tickets Available: 1 

 

The purpose of this Funding Opportunity Announcement (FOA) is to support dynamic, multidisciplinary consortia of structural biologists, virologists, and computational scientists to resolve complex biological structures relevant to HIV prevention, treatment, and cure. The consortia are expected to leverage common resources, facilitate new collaborations, and engage and support the next generation of HIV structural biology researchers.

No applicants.

Internal Deadline
External Deadline
10/13/2021